BruceColstonTrapnellMD

Critical Care Medicine

Professor, Pediatrics, University of Cincinnati College of Medicine

Dr. Trapnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
222 Piedmont Ave
Ste 6000
Cincinnati, OH 45219
Phone+1 513-475-7521

Fax+1 513-475-7327

Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1989
Clinical Center at the National Institutes of HealthFellowship, Pulmonary Disease and Critical Care Medicine, 1987 - 1988
Ohio State University HospitalResidency, Internal Medicine, 1984 - 1987
University of Maryland School of MedicineClass of 1984

PubMed

Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease.
Jonathan R Dillman, Jean A Tkach, Joel G Fletcher, David H Bruining, Aiming Lu
Inflammatory Bowel Diseases. 2025-01-24
Lung immune incompetency after mild peritoneal sepsis and its partial restoration by type 1 interferon: a mouse model study.
Qiuming Meng, Fumiko Seto, Tokie Totsu, Tomoyuki Miyashita, Songfei Wu
Intensive Care Medicine Experimental. 2024-12-20
3 citations
MRI and Blood-based Biomarkers Are Associated With Surgery in Children and Adults With Ileal Crohn's Disease.
Jonathan R Dillman, Jean A Tkach, Joel G Fletcher, David H Bruining, Aiming Lu
Inflammatory Bowel Diseases. 2024-11-04

Journal Articles

Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis
Bruce Trapnell, MD, New England Journal of Medicine

Savara Announces New Data from Pivotal Phase 3 IMPALA-2 Trial of Molgramostim Nebulizer Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Were Presented at the European Respiratory Society (ERS) Congress 2024September 8th, 2024
Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) TrialJune 30th, 2021
New England Journal of MedicineSeptember 8th, 2020
Join now to see all

Role Of GM-CSF In Myeloid Cell Function And Innate ImmunityNational Heart, Lung, And Blood Institute2011–2012
Macrophage-Based Human Gene Therapy For Hereditary PAPNational Heart, Lung, And Blood Institute2011–2012
Role Of Anti-Gm-Csf Antibodies In Myeloid Cell Function &Innate ImmunityNational Heart, Lung, And Blood Institute2010
Role Of Anti-Gm-Csf Antibodies In Myeloid Cell Function &Innate ImmunityNational Heart, Lung, And Blood Institute2007–2009
Quantitative Chest Computed Tomography In Alpha-1-Antitrypsin DeficiencyNational Center For Research Resources2008
Anticytokine Autoantibodies/Growth Factors In RARE Lung DiseasesNational Center For Research Resources2005–2008
RARE Lung Disease Clinical Research NetworkNational Center For Research Resources2003–2008
AAT Deficiency &Liver Diseases Caused By ProteinsNational Institute Of Diabetes And Digestive And Kidney Diseases2006
Fourth Annual International Pulmonary Alveolar Proteinosis Research ConferenceNational Heart, Lung, And Blood Institute2006
Regulation Of Alveolar Macrophage PhagocytosisNational Heart, Lung, And Blood Institute2003–2006
Pulmonary Alveolar Proteinosis Research ConferenceNational Heart, Lung, And Blood Institute2005
Conference--Pulmonary Alveolar Proteinosis ResearchNational Heart, Lung, And Blood Institute2004
GM-CSF &Alveolar Macrophage Antiviral Lung DefenseNational Heart, Lung, And Blood Institute2001–2004
Core--Viral VectorsNational Heart, Lung, And Blood Institute1997